News Eli Lilly and Company Mexican S.E.

Equities

LLY *

US5324571083

End-of-day quote Mexican S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
16,691 ^MXN	+0.39%		+3.86%	+68.87%

05:20pm	Eli Lilly, Radionetics Oncology Strike Strategic Agreement	MT
04:26pm	Sanofi eyes German insulin investment of up to $1.6 bln, source says	RE

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Eli Lilly, Radionetics Oncology Strike Strategic Agreement	04:20pm	MT
Sanofi eyes German insulin investment of up to $1.6 bln, source says	03:26pm	RE
'HB': Sanofi plans to invest billions in Frankfurt	01:29pm	DP
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro	01:29pm	RE
Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Tesla to Advance, Nvidia to Decline	01:21pm	MT
Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study	06-28	MT
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	06-28	RE
India plans incentives for diabetes, obesity drug makers in 2026, government official says	06-28	RE
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	06-27	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	06-27	AQ
Augustine Therapeutics N.V. announced that it expects to receive funding from a group of investors	06-25	CI
Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls	06-25	MT
Eli Lilly Working With OpenAI to Develop Medicines Against Drug-Resistant Pathogens	06-25	DJ
Eli Lilly Teams Up With OpenAI to Develop Antimicrobials for Drug-Resistant Bacteria	06-25	MT
Eli Lilly: collaboration agreement with OpenAI	06-25	CF
Eli Lilly Partners With OpenAI for Developing Antimicrobials to Treat Drug-Resistant Bacteria	06-25	MT
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	06-25	PR
Out with AI, in with defensive stocks	06-25
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China	06-25	DJ
ANALYST RECOMMENDATIONS : Capri Holdings, Adobe, Broadcom, Celanese, Admiral...	06-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 06:47 pm